摘要
目的:探讨行为矫正联合哌罗匹隆治疗对精神分裂症患者社会功能及催乳素、体重的影响。方法:将62例精神分裂症患者随机分为两组,对照组(n=31)给予哌罗匹隆治疗,治疗组(n=31)在此基础上给予行为矫正治疗,包括生活自理、社会生活及社交能力训练,持续3个月。采用阳性和阴性症状量表(PANSS)、个人和社会功能量表(PSP)评估患者精神症状及社会功能方面的变化,检测患者泌乳素及体重变化,采用副反应量表(TESS)评估不良反应严重程度。结果:干预3个月后,两组患者PANSS总分减分率较干预1个月后增加,且治疗组PANSS总分减分率高于对照组(P<0.05)。干预1、3个月后,治疗组PSP评分、TESS评分较干预前均改善,且干预3个月后治疗组PSP评分高于对照组(P<0.05),TESS评分低于对照组(P<0.05)。干预前、干预1、3个月两组患者泌乳素水平、体重组内及组间同期比较,差异均无统计学意义(P>0.05)。结论:精神分裂症患者在哌罗匹隆治疗基础上引入行为矫正治疗,可进一步改善患者的精神症状、社会功能,对泌乳素水平和体重影响较小。
Objective:To explore the influence of behavior modification therapy combined with perospirone on the social function,prolactin level and body weight in the patients with schizophrenia(SCZ).Methods:62 SCZ patients were randomly divided into two groups:the control group(n=31)was given perospirone,and the treatment group(n=31)was given behavior modification therapy on the base of the control group,including activities of daily living,social life and social ability training,all for 3 months.Positive and negative symptom scale(PANSS)and personal and social performance scale(PSP)were used to evaluate the psychiatric symptoms and social function,and the prolactin level and body weight of the patients were measured.The severity of adverse reactions was assessed using the TESS scale.Results:3 months after intervention,the total score reduction rate of PANSS in the two groups was higher lower than that at 1 month after intervention,and the total score reduction rate of PANSS in the treatment group was higher lower than that in the control group(P<0.05).After 1 and 3 months of intervention,the PSP score and TESS score of patients in the treatment group was significantly improved compared with those before intervention.After the 3 months,PSP score of the treatment group was higher than that in the control group(P<0.05),and the TESS score in the treatment group was lower than that in the control group(P<0.05).There were no statistical differences in prolactin level and body weight before intervention,1 and 3 months after intervention between and within the two groups(P>0.05).Conclusion:Behavior modification therapy combined with perospirone can further improve the mental symptoms,social function of SCZ patients,and has little effect on the prolactin level and body weight.
作者
冒海瀛
周争轶
杨建军
MAO Haiying;ZHOU Zhengyi;YANG Jianjun(Department of Psychiatry, Shanghai Baoshan District Mental Health Center, Shanghai 201900, China)
出处
《中国医药导刊》
2022年第2期152-155,共4页
Chinese Journal of Medicinal Guide
关键词
精神分裂症
行为矫正治疗
哌罗匹隆
内分泌
社会功能
Schizophrenia
Behavior modification therapy
Perospirone
Endocrine
Social function
